Group One Trading’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.6K | Buy |
7,198
+612
| +9% | +$5.15K | ﹤0.01% | 5043 |
|
|
2025
Q4 | $53.6K | Buy |
6,586
+556
| +9% | +$6.86K | ﹤0.01% | 5549 |
|
|
2025
Q3 | $76.3K | Buy |
+6,030
| New | +$57.4K | ﹤0.01% | 5578 |
|
|
2025
Q1 | – | Sell |
-8,158
| Closed | -$72K | – | 7700 |
|
|
2024
Q4 | $96.3K | Buy |
+8,158
| New | +$137K | ﹤0.01% | 4549 |
|
|
2024
Q2 | – | Sell |
-401
| Closed | -$16.9K | – | 6829 |
|
|
2024
Q1 | $15.7K | Sell |
401
-1,399
| -78% | -$34.5K | ﹤0.01% | 5598 |
|
|
2023
Q4 | $10.9K | Sell |
1,800
-230
| -11% | -$1.24K | ﹤0.01% | 6142 |
|
|
2023
Q3 | $13.7K | Sell |
2,030
-15
| -0.7% | -$104 | ﹤0.01% | 6160 |
|
|
2023
Q2 | $16K | Sell |
2,045
-220
| -10% | -$1.98K | ﹤0.01% | 6129 |
|
|
2023
Q1 | $16.5K | Sell |
2,265
-2,049
| -47% | -$8.96K | ﹤0.01% | 5637 |
|
|
2022
Q4 | $14.3K | Sell |
4,314
-106
| -2% | -$408 | ﹤0.01% | 5827 |
|
|
2022
Q3 | $22K | Sell |
4,420
-257
| -5% | -$1.81K | ﹤0.01% | 5999 |
|
|
2022
Q2 | $35K | Buy |
4,677
+480
| +11% | +$4.64K | ﹤0.01% | 5860 |
|
|
2022
Q1 | $67K | Sell |
4,197
-1,803
| -30% | -$23.9K | ﹤0.01% | 5865 |
|
|
2021
Q4 | $111K | Buy |
6,000
+1,301
| +28% | +$35.2K | ﹤0.01% | 5642 |
|
|
2021
Q3 | $144K | Buy |
4,699
+2,007
| +75% | +$79.2K | ﹤0.01% | 5514 |
|
|
2021
Q2 | $148K | Sell |
2,692
-1,731
| -39% | -$96.1K | ﹤0.01% | 5554 |
|
|
2021
Q1 | $261K | Sell |
4,423
-598
| -12% | -$39.3K | ﹤0.01% | 4737 |
|
|
2020
Q4 | $188K | Sell |
5,021
-12,868
| -72% | -$481K | ﹤0.01% | 4093 |
|
|
2020
Q3 | $966K | Buy |
17,889
+14,679
| +457% | +$2.66M | ﹤0.01% | 2226 |
|
|
2020
Q2 | $808K | Sell |
3,210
-1,517
| -32% | -$307K | ﹤0.01% | 2225 |
|
|
2020
Q1 | $743K | Buy |
4,727
+3,397
| +255% | +$574K | 0.01% | 1753 |
|
|
2019
Q4 | $218K | Buy |
1,330
+3
| +0.2% | +$443 | ﹤0.01% | 3108 |
|
|
2019
Q3 | $194K | Sell |
1,327
-477
| -26% | -$83.1K | ﹤0.01% | 3100 |
|
|
2019
Q2 | $375K | Sell |
1,804
-1,317
| -42% | -$282K | ﹤0.01% | 2398 |
|
|
2019
Q1 | $651K | Buy |
3,121
+1,291
| +71% | +$285K | 0.01% | 1746 |
|
|
2018
Q4 | $321K | Buy |
1,830
+1,321
| +260% | +$264K | ﹤0.01% | 2324 |
|
|
2018
Q3 | $115K | Buy |
509
+239
| +89% | +$38.6K | ﹤0.01% | 3429 |
|
|
2018
Q2 | $41K | Sell |
270
-542
| -67% | -$98.5K | ﹤0.01% | 4053 |
|
|
2018
Q1 | $149K | Sell |
812
-1,373
| -63% | -$308K | ﹤0.01% | 2988 |
|
|
2017
Q4 | $465K | Buy |
2,185
+724
| +50% | +$155K | ﹤0.01% | 2315 |
|
|
2017
Q3 | $313K | Buy |
1,461
+965
| +195% | +$189K | ﹤0.01% | 2435 |
|
|
2017
Q2 | $94K | Buy |
+496
| New | +$97.3K | ﹤0.01% | 3147 |
|
Other funds holding CRBP
CAM
O
VCM
PM
DP
SCM
AC
Group One Trading's CRBP Position: Q1 2026 in Review
Group One Trading increased its Corbus Pharmaceuticals (CRBP) stake by 9.3% in Q1 2026, buying an estimated $5.15K and bringing the position to 7,198 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5043.
Group One Trading first reported a position in CRBP in Q2 2017 and has held it in 32 quarters since. The position peaked at $966K in Q3 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.
- Group One Trading held 7,198 shares of Corbus Pharmaceuticals worth $67.6K as of Q1 2026.
- Group One Trading bought 612 Corbus Pharmaceuticals shares in Q1 2026, an estimated $5.15K.
- Corbus Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5043 holding.
- Group One Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 32 quarters since.
- Group One Trading's Corbus Pharmaceuticals position peaked at $966K in Q3 2020.
- 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.